Join to View Full Profile
901 LAKESHORE DRSTE 208Ishpeming, MI 49849
Dr. Afshinnia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Farsad Afshinnia is a nephrologist based in Ann Arbor, MI. He serves as Associate Professor of Medicine at the University of Michigan. He completed his fellowship in nephrology at the University of Michigan (2010-2012) and his residency in internal medicine at One Brooklyn Health System/Brookdale University Hospital (2002-2005). He graduated from Isfahan University of Medical Sciences in 1996. Dr. Afshinnia has published research on topics such as chronic kidney disease and lipid metabolism, with several articles cited by other publications. He has received CMS Meaningful Use Stage 1 and Stage 2 Certifications across various Epic Systems Corporation modules.
Education & Training
University of MichiganFellowship, Nephrology, 2010 - 2012
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2002 - 2005
Isfahan University of Medical SciencesClass of 1999
Certifications & Licensure
MI State Medical License 2009 - 2028
CA State Medical License 2005 - 2025
MN State Medical License 2007 - 2025
WA State Medical License 2024 - 2025
NJ State Medical License 2005 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2017
Publications & Presentations
PubMed
- Chronic kidney disease induces distinct alterations of macrophage lipid metabolism in a mouse model of atherosclerosis.Keith Saum, Xinyi Liu, Thekkelnaycke Rajendiran, Lixia Zeng, Pradeep Kayampilly
Journal of Lipid Research. 2026-02-01 - Voclosporin Induces Systemic Lipidomic Alterations: Implications for Lupus Nephritis Remission.Farsad Afshinnia, Thekkelnaycke M Rajendiran, Jaeman Byun, Manikanta Swamy Arnipalli, Linda M Rehaume
Kidney International Reports. 2024-08-01 - 5 citationsTubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease.Anna V Mathew, Pradeep Kayampilly, Jaeman Byun, Viji Nair, Farsad Afshinnia
American Journal of Physiology. Renal Physiology. 2024-01-01
Press Mentions
Precision Medicine Helps Identify "At-Risk Rapid Decliners" in Early-Stage Kidney DiseaseJuly 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
